Conformation-X Therapeutics
Canton
About Conformation-X Therapeutics
Conformation-X Therapeutics is an immune-oncology focused drug development company.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $8.2M
- Funding stage: Seed
- Last round: Seed (Apr 2024)
- Website: conformationx.com
Industries & Categories
Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/conformation-x-therapeutics-41878 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.